JPH01296999A - Measurement of living body specimen - Google Patents
Measurement of living body specimenInfo
- Publication number
- JPH01296999A JPH01296999A JP12394288A JP12394288A JPH01296999A JP H01296999 A JPH01296999 A JP H01296999A JP 12394288 A JP12394288 A JP 12394288A JP 12394288 A JP12394288 A JP 12394288A JP H01296999 A JPH01296999 A JP H01296999A
- Authority
- JP
- Japan
- Prior art keywords
- dehydrogenase
- living body
- substrate
- content
- body specimen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000005259 measurement Methods 0.000 title description 6
- 101710088194 Dehydrogenase Proteins 0.000 claims abstract description 29
- 239000000758 substrate Substances 0.000 claims abstract description 16
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 claims abstract description 6
- 102000003992 Peroxidases Human genes 0.000 claims abstract description 5
- 108040007629 peroxidase activity proteins Proteins 0.000 claims abstract description 5
- 238000006356 dehydrogenation reaction Methods 0.000 claims abstract description 4
- 239000012472 biological sample Substances 0.000 claims description 14
- 239000000523 sample Substances 0.000 claims description 4
- 238000000691 measurement method Methods 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 abstract description 19
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 abstract description 12
- 238000004020 luminiscence type Methods 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 4
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 abstract 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 229950006238 nadide Drugs 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 108020005199 Dehydrogenases Proteins 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000005970 1-Naphthylacetamide Substances 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ORIIXCOYEOIFSN-UHFFFAOYSA-N 1,3-benzothiazol-6-ol Chemical compound OC1=CC=C2N=CSC2=C1 ORIIXCOYEOIFSN-UHFFFAOYSA-N 0.000 description 1
- MASUWVVNWALEEM-UHFFFAOYSA-M 1-methoxy-5-methylphenazin-5-ium;methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2N=C3C(OC)=CC=CC3=[N+](C)C2=C1 MASUWVVNWALEEM-UHFFFAOYSA-M 0.000 description 1
- SQAVNBZDECKYOT-UHFFFAOYSA-N 6-hydroxy-1,3-benzothiazole-2-carbonitrile Chemical compound OC1=CC=C2N=C(C#N)SC2=C1 SQAVNBZDECKYOT-UHFFFAOYSA-N 0.000 description 1
- 102000004567 6-phosphogluconate dehydrogenase Human genes 0.000 description 1
- 108020001657 6-phosphogluconate dehydrogenase Proteins 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 1
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 1
- ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 description 1
- 108091006149 Electron carriers Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 1
- 108700023156 Glutamate dehydrogenases Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Natural products OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000007357 dehydrogenase reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- OKISBDHRUPZLOC-UHFFFAOYSA-N gallin Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC=C(O)C(O)=C2OC2=C(O)C(O)=CC=C21 OKISBDHRUPZLOC-UHFFFAOYSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- -1 heat treatment Chemical compound 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Natural products OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、生体試料の測定方法に関し、さらに詳しくは
、生体試料中の脱水素酵素含有率または脱水素酵素の基
質含有率の測定方法に係わる。[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to a method for measuring a biological sample, and more particularly, to a method for measuring a dehydrogenase content or a dehydrogenase substrate content in a biological sample. Involved.
〔従来技術、・発明が解決しようとする問題点〕生体試
料中の脱水素酵素含有率および脱水素酵素の基質の含有
率は、脱水素酵素の反応によって生成される還元をエコ
チンアミド−アデニン−ジヌクレオチド(以下 NAD
Hと記す)の量または還元型ニコチンアミド−アデニン
−ジヌクレオチドりん酸(以下 NADPHと配子)の
量を測定することにより、求めることが出来る。[Prior art, problem to be solved by the invention] The dehydrogenase content and the dehydrogenase substrate content in a biological sample are determined to reduce the reduction produced by the dehydrogenase reaction by reducing ecotinamide-adenine-dihydrogenase. Nucleotide (hereinafter referred to as NAD)
It can be determined by measuring the amount of NADPH (denoted as H) or the amount of reduced nicotinamide-adenine dinucleotide phosphate (hereinafter referred to as NADPH and ligand).
従来、このNADHあるいはNADPHの測定方法とし
ては、■340 nmの吸光度でNADHまたは、NA
DPHな測定する方法 ■たとえば、フ凰ナジン メタ
サルフェー) (PMS)および1−メトキシ−PMS
などのような電子伝達体およびホルマザンをNADHま
たは、NADPHに作用させ、生成されたジホルマザン
色素を可視部の吸光度で測定する方法 などが知られて
いる。Conventionally, the method for measuring NADH or NADPH is: ■ measuring NADH or NADH with absorbance at 340 nm
Method for measuring DPH ■For example, fuo-nadine metasulfate (PMS) and 1-methoxy-PMS
A method is known in which an electron carrier and formazan, such as E.g.
しかしながら、これらの方法では、NADHあるいはN
ADPHの検出感度が低くて実用上十分でなく、より高
い感度で測定出来る方法の開発が1まれていた。However, in these methods, NADH or N
The detection sensitivity of ADPH is low and insufficient for practical use, and there has been a need to develop a method that can measure with higher sensitivity.
本発明者らは、生体試料中の脱水素酵素および脱水素酵
素の基質のそれぞれの含有率を再現性よく、しかも高感
度に測定できる方法を種々検討したところ、脱水素反応
により生成されたNADHあるいはNADPHにピロロ
キノリ/キノン類、ペルオキシダーゼおよびルミノール
を作用させることによりルミノールが酸化されて、化学
発光が生じ、その強度は、NADHの1またはNADP
Hの量に比例し、かつ、NADHまたは、NADPHが
微量でも測定できることを見出した。この新知見に基づ
いて本発明tこ到達した。The present inventors investigated various methods that could reproducibly and highly sensitively measure the content of dehydrogenase and dehydrogenase substrate in biological samples, and found that NADH produced by the dehydrogenation reaction Alternatively, by reacting pyrroloquinol/quinones, peroxidase, and luminol with NADPH, luminol is oxidized and chemiluminescence is generated, the intensity of which is 1 of NADH or 1 of NADP.
It has been found that the amount of NADH or NADPH is proportional to the amount of H, and that even a trace amount of NADH or NADPH can be measured. The present invention has been achieved based on this new knowledge.
すなわち、本発明は、生体試料中の脱水素酵素および脱
水素酵素の基質のでれぞれの含有率の測定:こ際して、
脱水素反応により生成されたNAD HまたIj N
A D P Hにビpロキノリンキ作用させ、発生した
化学発光の強度を測定するする生体試料の測定法である
。That is, the present invention provides a method for measuring the content of dehydrogenase and dehydrogenase substrate in a biological sample:
NAD H or Ij N produced by dehydrogenation reaction
This is a biological sample measurement method in which biproquinoline is applied to ADPH and the intensity of chemiluminescence generated is measured.
本発明において使用される生体試料としては、動物、植
物あるいは微生物などに由来する試料などがあり、代表
例として、血液、限および痰など、ならびに各生物体の
抽出物、微生物および細胞の培養液などがある。Biological samples used in the present invention include samples derived from animals, plants, microorganisms, etc. Typical examples include blood, phlegm, and sputum, as well as extracts of various living organisms, and culture fluids of microorganisms and cells. and so on.
これらの試料に含まれる各種の脱水素酵素の測定に、ま
た、これらの試料に含まれる物質の中の脱水素酵素の基
質となる物質の測定に、それぞれ本発明を適用すること
により、これらの物質を高感度に測定することが可能と
なる。By applying the present invention to the measurement of various dehydrogenases contained in these samples, and to the measurement of substances that are substrates for dehydrogenases among the substances contained in these samples, these It becomes possible to measure substances with high sensitivity.
生体試料中の脱水素酵素および±力説水素酵素の基質の
それぞれの含有率を測定するに関して、その工程を、次
の二つの工程に分けることが出来る。The process of measuring the respective contents of dehydrogenase and +/-hydrogenase substrates in a biological sample can be divided into the following two steps.
第一工程は、生体試料中よりNADHあるいはNADP
H(以下 NADHまたはNADPHを一括して NA
D CP)Hと記すことがある。NAD (P)につい
てもこれに準する)を生じさせる工程である。The first step is to extract NADH or NADP from the biological sample.
H (hereinafter referred to as NADH or NADPH collectively)
DCP)H may be written. This process also applies to NAD (P).
脱水素酵素
脱水素酵素の塁を測定する場合)よ、この酵素の基質お
よびNAD (P)を反応液に添加し、また、脱水素酵
素の基質の量を測定する場合は、脱水素酵素とNAD
(P)とを反応液に添加し、反応させることにより、N
ADHまたt’!、NADか0
PH−薪生成される。When measuring the base of dehydrogenase (dehydrogenase), add the substrate of this enzyme and NAD (P) to the reaction solution, and when measuring the amount of the substrate of dehydrogenase, add N.A.D.
By adding (P) to the reaction solution and reacting, N
ADH again t'! , NAD or 0 PH-firewood is generated.
発生する工程であるが、その反応を二次式によると推測
され恰←る。Although this is a process that occurs, it is assumed that the reaction is based on a quadratic equation.
PQQ +
NAD (P) H−4−02+ H+−−)NAD
Q’) + H2O2第−工程の反応と第二工程の反
応とを、同一の反応液中で行なうことも可能であるが、
生体試料によっては、これに、混入されている不純物が
第二工程での発光を主書する場合もあるので、第一工程
を行なう前、あるいは行なった後に混在する不純物を除
去し、このようにして得られたサンプルを第二工程會こ
供することが好ましい。PQQ + NAD (P) H-4-02+ H+--)NAD
Q') + H2O2 It is also possible to perform the reaction in the first step and the reaction in the second step in the same reaction solution,
Depending on the biological sample, impurities mixed into the sample may be the main cause of light emission in the second step, so remove the mixed impurities before or after the first step. It is preferable to subject the sample obtained by the second step to a second step.
この場合の処理方法としては、酵素などのたん白の不活
性化あるいは除去、また、鉄などの金属を取り除く処理
など−たとえば熱処理、樹脂吸着処理、溶剤変性など−
がある。Treatment methods in this case include inactivation or removal of proteins such as enzymes, and treatment to remove metals such as iron, such as heat treatment, resin adsorption treatment, solvent denaturation, etc.
There is.
第二工程において、発生した化学発光を測定する方法と
しては、一般の放射能測定用のシンする検光器などを用
いる方法が採用される。In the second step, as a method for measuring the generated chemiluminescence, a method using a general spectrometer for measuring radioactivity or the like is adopted.
このようにして、生体試料中の脱水素酵素含有率または
脱水素酵素の基質の含有率を、従来の方法に比べて10
〜100倍の感度で測定することが出来る。In this way, the dehydrogenase content or dehydrogenase substrate content in biological samples can be reduced by 10% compared to conventional methods.
Measurements can be made with up to 100 times the sensitivity.
さらに、この第二工程において、増感剤として、6−ヒ
ドロキシベンゾチアゾール、2−シアノ−6−ヒドロキ
シベンゾチアゾール、あるいは、2−(6−ヒドロキシ
−2−ベンゾチアゾリル)チア宛−4−カルボン酸(デ
ヒドロルシフェリン)などを添加することにより、生体
試料中の脱水素酵素含有率または、脱水素酵素の基質の
含有率をさらに約10倍の感度で測定することが可能と
なる。Furthermore, in this second step, 6-hydroxybenzothiazole, 2-cyano-6-hydroxybenzothiazole, or 2-(6-hydroxy-2-benzothiazolyl)thia-4-carboxylic acid ( By adding dehydrogenase (dehydrluciferin) or the like, it becomes possible to measure the dehydrogenase content or the dehydrogenase substrate content in a biological sample with about 10 times more sensitivity.
増感剤の濃度は、特に制限はなく、反応条件や測定時間
によって適宜設定される。The concentration of the sensitizer is not particularly limited and is appropriately set depending on the reaction conditions and measurement time.
脱水素酵素としては、たとえば、グルコース脱水素酵素
、フラクトース脱水素酵素、アルコール脱水素酵素、グ
ルコ−)臀イン酸脱水素酵素、アルデヒド脱水素酵素、
ホスホグルコン酸脱水素酵素、リンゴ酸脱水素酵素、イ
ンクエン酸脱水素酵素、グルタミ≠ン酸脱水素酵素およ
びアミン脱水素酵素などがある。Examples of dehydrogenases include glucose dehydrogenase, fructose dehydrogenase, alcohol dehydrogenase, glucophosphate dehydrogenase, aldehyde dehydrogenase,
These include phosphogluconate dehydrogenase, malate dehydrogenase, incitrate dehydrogenase, glutamate dehydrogenase, and amine dehydrogenase.
また、脱水素酵素の基質としては、たとえば、6−ホス
ホグルフン酸、リンゴ酸、イソクエン酸、グルタミン酸
およびアミン類などがある。In addition, examples of dehydrogenase substrates include 6-phosphoglufunic acid, malic acid, isocitric acid, glutamic acid, and amines.
本発明に用いられるビーロキノリンキノン類とは、ピロ
ロキノリソキノン(別名、2,7゜9−トリカルボキシ
−IH−ピロロ(2、3f)キノリンキノン−4,5−
ジオンtゴ11r寸−+−冊ヰ) 、PQQのナトリウ
ム塩およびPQQのカリウム塩などのPQQ塩類、なら
びにPQQ誘導体を意味する。PQQ誘導体の代表例と
しては、1−メチル−PQQ、7−ゾカルボキーPQQ
、2−メチルエステル−PQQなどがある。これらPQ
Q類の添加量は、試料の種類、反応条件および測定時間
によって適宜設定される。PQQ類はNAD (P)に
対して等モル必要であるが、実用上はこの10〜200
倍の量が使用される。なお、こhより多く使用すること
を妨げない。The beer-quinoline quinones used in the present invention are pyrroloquinolisoquinone (also known as 2,7゜9-tricarboxy-IH-pyrrolo(2,3f)quinolinequinone-4,5-
PQQ salts, such as sodium salt of PQQ and potassium salt of PQQ, and derivatives of PQQ. Representative examples of PQQ derivatives include 1-methyl-PQQ, 7-zocarboxy PQQ
, 2-methyl ester-PQQ, and the like. These PQ
The amount of Class Q added is appropriately set depending on the type of sample, reaction conditions, and measurement time. PQQs are required in an equimolar amount to NAD (P), but in practical terms this amount is 10 to 200
Twice the amount is used. Note that there is no hindrance to using more than this.
また、使用されるペルオキシダーゼは、H2O2+AH
2→2HzO+Aを触媒台する活性を有する酵素であれ
ばよく、動物、植物または、微生物のいずれの由来のも
のでもよい。これらの酵素の濃度は、特に制限されない
が、1〜30 tJnit/−の範囲、特に1 、5〜
15 Unit/al!が好ましい。なお、この1Un
itは、pH6、0,20℃で20秒間にピロガロール
(1,2,3−トリヒドロキシベンゼン)からImgの
プルプμガリン(2、3、4、6−テトラヒドロキシ−
5H−ベンゾシクロへブテン−5−オン)を生成させる
活性と1.て示される。Additionally, the peroxidase used is H2O2+AH
Any enzyme may be used as long as it has the activity of catalyzing 2→2HzO+A, and may be derived from animals, plants, or microorganisms. The concentration of these enzymes is not particularly limited, but ranges from 1 to 30 tJnit/-, especially from 1 to 30 tJnit/-.
15 units/al! is preferred. In addition, this 1Un
It was prepared by converting Img of purp gallin (2,3,4,6-tetrahydroxy-
5H-benzocyclohebuten-5-one) and 1. is shown.
さらに使用されるルミノール(5−アミノ−2,3−ジ
ヒドR−1,4〜フタラジンジオン)の濃度は、特に制
限はないが1〜30μmo I e/1の範囲、さらに
特に2〜10μmo I e/l が好ましい。反応
液のpH1!通常4〜10であり%5−−e〜8→が特
に好ましい。反応温度も特に制限はないが、通常は20
〜40℃の範囲で行なわれる。Furthermore, the concentration of luminol (5-amino-2,3-dihydro R-1,4-phthalazinedione) used is not particularly limited, but is in the range of 1 to 30 μmol I e/1, more particularly 2 to 10 μmol I e/l is preferred. The pH of the reaction solution is 1! It is usually 4 to 10, and %5--e to 8→ is particularly preferable. There is no particular restriction on the reaction temperature, but it is usually 20
It is carried out in the range of ~40°C.
以下、実施例によって本発明をさらに具体的に説明する
。Hereinafter, the present invention will be explained in more detail with reference to Examples.
実施例 1
反応液として、後記の(A)を用い、25°Cで攪拌し
ながらプレインキエベートした。約5社製のLum1n
escence Reader BLR,−102を用
いで反応生成液の発光強度を測定した。Example 1 Using (A) described below as a reaction solution, pre-incubation was carried out at 25°C with stirring. Lum1n made by about 5 companies
The luminescence intensity of the reaction product liquid was measured using Escence Reader BLR, -102.
反応液
合計 1−
NAD (P)H濃度と発光強度との関係を図1に示す
。Total reaction solution 1-NAD The relationship between the (P)H concentration and the luminescence intensity is shown in FIG.
反応液中のNAD (P)H濃度として、約5μno
I e/l まで定量が可能である。The NAD(P)H concentration in the reaction solution was approximately 5 μno
Quantification is possible up to I e/l.
実施例 2
反応液として、下記の(B)を用い、25℃で攪拌しな
がらブレインキュベートした。約5各濃度になるよう艮
、各々20μl添加して反応さ1、直、、1ツオ噴鴫つ
、−あいアゆ力比製のLum1nescence Re
ader BLR−102を用いて反応生成液の発光強
度を測定した。Example 2 The following (B) was used as a reaction solution, and the mixture was incubated at 25° C. with stirring. Add 20 μl of each to a concentration of about 5 and react.
The luminescence intensity of the reaction product solution was measured using Ader BLR-102.
反応液
各濃度のNAD (P)H水溶液
20μ!合計 1−
NAD (P)H濃度と発光強度との関係を図2に示す
。Reaction solution NAD (P)H aqueous solution at various concentrations
20μ! The relationship between total 1-NAD(P)H concentration and luminescence intensity is shown in FIG. 2.
反応液中のNAD (P)H濃度として、約0゜5μm
ole/lまで定量が可能である。The NAD(P)H concentration in the reaction solution is approximately 0.5 μm.
Quantification is possible down to ole/l.
各種の臨床検査に利用することが出来る。 It can be used for various clinical tests.
図1および図2は、いずれも、NAD (P)H濃度と
発光強度との関係を示すグラフである。
特許出願人 三菱瓦斯化学株式会社
代表者長野和吉Both FIGS. 1 and 2 are graphs showing the relationship between NAD (P)H concentration and luminescence intensity. Patent applicant Kazuyoshi Nagano, representative of Mitsubishi Gas Chemical Co., Ltd.
Claims (1)
れの含有率の測定に際して、脱水素反応により生成され
た還元型エコチンアミド−アデニン−ジヌクレオチドま
たは還元型ニコチソアミド−アデニン−ジヌクレオチド
りん酸にピロロキノリソキノン類、ペルオキシダーゼお
よびルミノールを作用させ、発生した化学発光の強度を
測定することにより、生体試料中の脱水素酵素の含有率
または脱水素酵素の基質の含有率を知ることを特徴とす
る生体試料の測定法。When measuring the content of dehydrogenase and dehydrogenase substrate in a biological sample, pyrroloquinone is added to reduced ecotinamide-adenine-dinucleotide or reduced nicotisoamide-adenine-dinucleotide phosphate produced by the dehydrogenation reaction. A living body characterized by knowing the content of dehydrogenase or the content of a substrate for dehydrogenase in a biological sample by treating lysoquinones, peroxidase, and luminol and measuring the intensity of chemiluminescence generated. Sample measurement method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12394288A JP2712290B2 (en) | 1988-05-23 | 1988-05-23 | Measurement method for biological samples |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12394288A JP2712290B2 (en) | 1988-05-23 | 1988-05-23 | Measurement method for biological samples |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01296999A true JPH01296999A (en) | 1989-11-30 |
JP2712290B2 JP2712290B2 (en) | 1998-02-10 |
Family
ID=14873165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12394288A Expired - Lifetime JP2712290B2 (en) | 1988-05-23 | 1988-05-23 | Measurement method for biological samples |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2712290B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995029255A1 (en) * | 1994-04-21 | 1995-11-02 | Medilite Diagnostika | Luminescence-based diagnostics |
-
1988
- 1988-05-23 JP JP12394288A patent/JP2712290B2/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995029255A1 (en) * | 1994-04-21 | 1995-11-02 | Medilite Diagnostika | Luminescence-based diagnostics |
US5624813A (en) * | 1994-04-21 | 1997-04-29 | Mahant; Vijay K. | NAD(P)+ /NAD(P)H based chemiluminescent diagnostics |
Also Published As
Publication number | Publication date |
---|---|
JP2712290B2 (en) | 1998-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Akyilmaz et al. | A biosensor based on urate oxidase–peroxidase coupled enzyme system for uric acid determination in urine | |
Nanjo et al. | Enzyme electrode sensing oxygen for uric acid in serum and urine | |
EP0496730B1 (en) | Method and reagent for determination of an analyte via enzymatic means using a ferricyanide/ferric compound system | |
Wangsa et al. | Fiber-optic biosensors based on the fluorometric detection of reduced nicotinamide adenine dinucleotide | |
Casero et al. | Peroxidase enzyme electrodes as nitric oxide biosensors | |
Wang et al. | Flow injection analysis of glucose based on its inhibition of electrochemiluminescence in a Ru (bpy) 32+–tripropylamine system | |
JP2005118014A (en) | Method of analysis and reagent used for the same | |
JPS61247400A (en) | Method for terminating reaction of isocitric acid dehydrogenase | |
JPS63226299A (en) | Selective determination of amino acid | |
JPH01296999A (en) | Measurement of living body specimen | |
JPS61247963A (en) | Quantitatively determining method for vital material with ammonia as resulted product of reaction | |
EP0207493A2 (en) | Method of terminating isocitrate dehydrogenase reaction | |
KR970001814B1 (en) | Process for measuring the content of component in vital fluid | |
JP2004024254A (en) | Method for simply measuring myoinositol | |
JPH05196601A (en) | New electrochemical measuring method | |
JPH04346796A (en) | Highly sensitive quantitative analysis of lactic acid or pyruvic acid and composition used for the same analysis | |
JPH02100699A (en) | Measurement of organism sample | |
JPH02145196A (en) | Method for determining magnesium | |
JPS626700A (en) | Measurement of biological substance using ammonia as reaction product | |
Racek | Lactate biosensor based on human erythrocytes | |
JPH02255098A (en) | Method for determining guanidinoacetic acid | |
CN115420694A (en) | Glutamate dehydrogenase determination kit | |
JPH06113890A (en) | Method for detecting catechol compound | |
JPS62232400A (en) | Determination of ornithine carbamoyl transferase or citrulline | |
JPH02200200A (en) | Determining method of nadh and determination of bile acid using the same method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081031 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081031 Year of fee payment: 11 |